Agenda

Return

C.122

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	September 7, 2021

Contra

Costa

County

Subject:

Purchase Order with Werfen USA, LLC

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 09/07/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Ronny Leffel Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: September 7, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, a Purchase Order with Werfen USA, LLC., in an amount not to exceed $534,000 for purchase of the reagents and supplies for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, for the period from May 1, 2021 through April 30, 2026.

FISCAL IMPACT:

Approval of this action will result in annual expenditures of up to $534,000 over a five (5) year period and will be funded 100% by Hospital Enterprise Fund I revenues.

BACKGROUND:

The CCRMC Clinical Laboratory owns Werfen’s hemostasis diagnostic equipment. The analyzers perform the statistical model used for the calibration of thromboplastins to derive the International Sensitivity Index (ISI) and the International Normalized Ratio (INR) required for the treatment of Coumadin patients. There is a contractual obligation and liability for the accuracy of the test results and maintenance of equipment by Werfen to utilize their specific reagents and related supplies.

BACKGROUND: (CONT'D)

The delay in execution of our request is due to a shortage in staffing and an oversight in the timely preparation and submission of this request.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, then the CCRMC Clinical Laboratory will not be able to perform the specific patient testing that utilizes these supplies, thus impacting patient safety and health.